<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02913573</url>
  </required_header>
  <id_info>
    <org_study_id>31801/1</org_study_id>
    <nct_id>NCT02913573</nct_id>
  </id_info>
  <brief_title>Effect of Pectoral Nerve Block on Post-op Pain in Patients Undergoing Mastectomy and Immediate Reconstruction</brief_title>
  <official_title>Pectoral Nerve Block vs. Standard Anesthesia in Patients Undergoing Mastectomy and Immediate Breast Reconstruction: Impact on Post-operative Pain and Nausea/Vomiting</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Huntington Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Huntington Memorial Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients undergoing total mastectomy with immediate breast reconstruction with a tissue
      expander or implant under general anesthesia will be randomly assigned to the addition of a
      pectoral nerve block or no regional block. Post-operative pain, nausea/vomiting scores will
      be assessed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients undergoing total mastectomy with immediate breast reconstruction with a tissue
      expander or implant under general anesthesia will be randomly assigned to the addition of a
      pectoral nerve block or no regional block after induction of general anesthesia and prior to
      the start of surgery. Post-operative pain scores and post-operative pain medication usage
      will be recorded. Post-operative nausea/vomiting scores and post-op anti-emetic medication
      usage will be recorded. The clinical impact of pectoral nerve block on this expanding
      population of patients will be determined.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post-op pain</measure>
    <time_frame>within first 48 hours</time_frame>
    <description>post-op pain assessed by Visual Analog Scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post-op nausea/vomiting</measure>
    <time_frame>within first 48 hours</time_frame>
    <description>post-op nausea/vomiting score assessed on standard scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Breast Neoplasm</condition>
  <arm_group>
    <arm_group_label>GA + Pec Block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Following induction of general anesthesia, the patients in the intervention group will undergo an ultrasound-guided pectoral block. With the patient in proper position, the infraclavicular and axillary regions are prepped with chlorhexidine. An US probe is placed below the third of the clavicle over the pectoralis major muscle. After identifying the appropriate anatomical structures, a 21-gauge echogenic needle is advanced under US visualization to the tissue plane between the pectoral major and pectoral minor muscles where the lateral and medial pectoralis nerves lie and 15 mL of 0.25% bupivacaine will be deposited. In a similar manner, 20 mL of 0.25% bupivacaine will be deposited under ultrasound-guidance at the level of the third rib above the serratus anterior muscle.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GA only</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients will receive standard general anesthesia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultrasound</intervention_name>
    <description>Pectoral nerve block is a regional block administered under ultrasound guidance which blocks the nerves of the thorax and chest areas.</description>
    <arm_group_label>GA + Pec Block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.25% bupivacaine</intervention_name>
    <description>Pectoral nerve block is a regional block administered under ultrasound guidance where 15 mL of 0.25% bupivacaine is instilled between the pectoral major and pectoral minor muscles where the lateral and medial pectoralis nerves lie. In a similar manner, 20 mL of 0.25% bupivacaine will be deposited under ultrasound-guidance at the level of the third rib above the serratus anterior muscle.</description>
    <arm_group_label>GA + Pec Block</arm_group_label>
    <other_name>0.25% Marcaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients age 18-90 years old

          2. Subjects able to read and understand the informed consent

          3. American Society of Anesthesiologists (ASA) physical status I and II

          4. Subjects scheduled to undergo unilateral or bilateral mastectomy with immediate breast
             reconstruction with submuscular placement of tissue expander or permanent implant
             under general anesthesia, including:

               -  subjects diagnosed with breast cancer

               -  subjects diagnosed with atypia or other high risk proliferative breast disease

               -  subjects with a family history who are considered at high risk for breast cancer
                  (including those with hereditary or genetic predisposition)

        Exclusion Criteria:

          1. Subjects unable to read or understand the informed consent

          2. ASA physical status III or IV

          3. Subjects with an allergy to local anesthetic

          4. Subjects with a medical contraindication to regional anesthetic, such as coagulopathy
             or local infection

          5. Subjects with a pre-existing submuscular implant

          6. Subjects scheduled to undergo mastectomy with myocutaneous flap reconstruction

          7. Subjects scheduled to undergo mastectomy without immediate reconstruction

          8. Subjects with a history of chronic pain or chronic opioid use
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeannie Shen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Huntington Memorial Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jeannie Shen, MD</last_name>
    <phone>(626) 356-3167</phone>
    <email>jeannie@jeannieshenmd.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Denise Pitt, JD</last_name>
    <phone>(626) 397-3674</phone>
    <email>denise.pitt@huntingtonhospital.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Huntington Memorial Hospital</name>
      <address>
        <city>Pasadena</city>
        <state>California</state>
        <zip>91105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Denise Pitt, JD</last_name>
      <phone>626-397-3764</phone>
      <email>denise.pitt@huntingtonhospital.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Bashandy GM, Abbas DN. Pectoral nerves I and II blocks in multimodal analgesia for breast cancer surgery: a randomized clinical trial. Reg Anesth Pain Med. 2015 Jan-Feb;40(1):68-74. doi: 10.1097/AAP.0000000000000163.</citation>
    <PMID>25376971</PMID>
  </results_reference>
  <results_reference>
    <citation>Leiman D, Barlow M, Carpin K, Pi√±a EM, Casso D. Medial and lateral pectoral nerve block with liposomal bupivacaine for the management of postsurgical pain after submuscular breast augmentation. Plast Reconstr Surg Glob Open. 2015 Jan 8;2(12):e282. doi: 10.1097/GOX.0000000000000253. eCollection 2014 Dec.</citation>
    <PMID>25587516</PMID>
  </results_reference>
  <results_reference>
    <citation>Blanco R, Fajardo M, Parras Maldonado T. Ultrasound description of Pecs II (modified Pecs I): a novel approach to breast surgery. Rev Esp Anestesiol Reanim. 2012 Nov;59(9):470-5. doi: 10.1016/j.redar.2012.07.003. Epub 2012 Aug 29.</citation>
    <PMID>22939099</PMID>
  </results_reference>
  <results_reference>
    <citation>Wu J, Buggy D, Fleischmann E, Parra-Sanchez I, Treschan T, Kurz A, Mascha EJ, Sessler DI. Thoracic paravertebral regional anesthesia improves analgesia after breast cancer surgery: a randomized controlled multicentre clinical trial. Can J Anaesth. 2015 Mar;62(3):241-51. doi: 10.1007/s12630-014-0285-8. Epub 2014 Dec 6.</citation>
    <PMID>25480319</PMID>
  </results_reference>
  <results_reference>
    <citation>Pei L, Zhou Y, Tan G, Mao F, Yang D, Guan J, Lin Y, Wang X, Zhang Y, Zhang X, Shen S, Xu Z, Sun Q, Huang Y; Outcomes Research Consortium. Ultrasound-Assisted Thoracic Paravertebral Block Reduces Intraoperative Opioid Requirement and Improves Analgesia after Breast Cancer Surgery: A Randomized, Controlled, Single-Center Trial. PLoS One. 2015 Nov 20;10(11):e0142249. doi: 10.1371/journal.pone.0142249. eCollection 2015.</citation>
    <PMID>26588217</PMID>
  </results_reference>
  <results_reference>
    <citation>Fahy AS, Jakub JW, Dy BM, Eldin NS, Harmsen S, Sviggum H, Boughey JC. Paravertebral blocks in patients undergoing mastectomy with or without immediate reconstruction provides improved pain control and decreased postoperative nausea and vomiting. Ann Surg Oncol. 2014 Oct;21(10):3284-9. doi: 10.1245/s10434-014-3923-z. Epub 2014 Jul 18.</citation>
    <PMID>25034821</PMID>
  </results_reference>
  <results_reference>
    <citation>Byrne K, Levins KJ, Buggy DJ. Can anesthetic-analgesic technique during primary cancer surgery affect recurrence or metastasis? Can J Anaesth. 2016 Feb;63(2):184-92. Review.</citation>
    <PMID>26497721</PMID>
  </results_reference>
  <results_reference>
    <citation>Cassinello F, Prieto I, del Olmo M, Rivas S, Strichartz GR. Cancer surgery: how may anesthesia influence outcome? J Clin Anesth. 2015 May;27(3):262-72. doi: 10.1016/j.jclinane.2015.02.007. Epub 2015 Mar 11. Review.</citation>
    <PMID>25769963</PMID>
  </results_reference>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 19, 2016</study_first_submitted>
  <study_first_submitted_qc>September 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 23, 2016</study_first_posted>
  <last_update_submitted>September 22, 2016</last_update_submitted>
  <last_update_submitted_qc>September 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 23, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Huntington Memorial Hospital</investigator_affiliation>
    <investigator_full_name>Jeannie Shen</investigator_full_name>
    <investigator_title>Director, Breast Surgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

